[{"AccountsPayableCurrent_0_Q3_USD":18456000.0,"PurchaseObligationDueInSecondAndThirdYear_0_Q3_USD":1200000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q3_USD":15900000.0,"PurchaseObligation_0_Q3_USD":17100000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":114000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":292000.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":0.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":241597000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":344136000.0,"PrepaidInsurance_0_Q3_USD":7995000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":14219000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":295000.0,"PreferredStockSharesAuthorized_0_Q3_shares":22840902.0,"PreferredStockDividendsPerShareDeclared_3_Q3_USD":0.0,"PreferredStockConvertibleConversionRatio_0_Q3_pure":1.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":122000.0,"PaymentsToAcquireInProcessResearchAndDevelopment_3_Q3_USD":4596000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":12000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-4605000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-1906000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":2828000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-487000.0,"OtherAssetsCurrent_0_Q3_USD":1050000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":234000.0,"OperatingIncomeLoss_3_Q3_USD":-315792000.0,"OperatingIncomeLoss_1_Q3_USD":-38314000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_GBP":0.002,"NumberOfOperatingSegments_3_Q3_segment":1.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":25850000.0,"ResearchAndDevelopmentInProcess_1_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":69597648.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":89899454.0,"ValueAddedTaxReceivable_0_Q3_USD":2945000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_GBP":0.0001,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":0.0,"StockRepurchasedAndRetiredDuringPeriodValue_3_Q3_USD":12000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":50000.0,"StockIssued1_3_Q3_USD":262698000.0,"StockholdersEquity_0_Q3_USD":549133000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":7.36,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":54126000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.29,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":7.47,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":10755205.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":101900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":7.47,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":11792647.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":987442.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":4.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":574267.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":7000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":8437705.0,"ShareBasedCompensation_3_Q3_USD":10093000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-324879000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":220454000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":5.84,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":89899454.0,"NetIncomeLoss_1_Q3_USD":-40155000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-78682000.0,"DebtConversionConvertedInstrumentAmount1_3_Q3_USD":6250000.0,"ConvertibleNotesPayableCurrent_0_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-317469000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-40642000.0,"CommonStockValue_0_Q3_USD":252000.0,"CommonStockSharesOutstanding_0_Q3_shares":89900425.0,"CommonStockSharesIssued_0_Q3_shares":89900425.0,"CommonStockSharesAuthorized_0_Q3_shares":89900425.0,"CommonStockParOrStatedValuePerShare_0_Q3_GBP":0.002,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":573849000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":578815000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":578815000.0,"DebtInstrumentDecreaseForgiveness_3_Q3_USD":6199000.0,"CashAcquiredFromAcquisition_3_Q3_USD":68038000.0,"Assets_0_Q3_USD":612207000.0,"AssetAcquisitionContingentConsiderationLiabilityNoncurrent_0_Q3_USD":33930000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11742566.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":11742566.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":0.0,"AmortizationOfDebtDiscountPremium_1_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":10093000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4133000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4133000.0,"AdditionalPaidInCapital_0_Q3_USD":871022000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":2738000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2324000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":10688000.0,"AssetsCurrent_0_Q3_USD":611645000.0,"NetIncomeLoss_3_Q3_USD":-320297000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":700000.0,"Depreciation_1_Q3_USD":15744.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":63320000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":585718000.0,"LoansPayableCurrent_0_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":29144000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":612207000.0,"Liabilities_0_Q3_USD":63074000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":100000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":65000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6149000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":7635000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":5529000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"DeferredFinanceCostsNoncurrentNet_0_Q3_USD":448000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":29900000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"ForeignCurrencyExchangeRateTranslation1_0_Q3_USD\/GBP":0.74,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":43000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2936000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":3493000.0,"EarningsPerShareDiluted_3_Q3_USD":-4.6,"EarningsPerShareDiluted_1_Q3_USD":-0.45,"EarningsPerShareBasic_3_Q3_USD":-4.6,"EarningsPerShareBasic_1_Q3_USD":-0.45,"DerivativeLiabilitiesCurrent_0_Q3_USD":0.0,"DepreciationDepletionAndAmortization_3_Q3_USD":22000.0,"Depreciation_3_Q3_USD":22551.0,"GeneralAndAdministrativeExpense_1_Q3_USD":12464000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":69597648.0,"Ticker":"CNTA","CIK":"1847903","name":"CENTESSA PHARMACEUTICALS PLC","OfficialName":"Centessa Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"866864446.0","Country":"United Kingdom","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]